BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Indapta Therapeutics Presents Clinical and Preclinical Data of Allogenic Natural Killer Cell Therapy at Society for Immunotherapy of Cancer Meeting

  November 7, 2024

   · 

  4 min read
• Press Releases

  Nimbus Therapeutics Presents Positive Updated Data from Phase 1/2 Clinical Trial of HPK1 Inhibitor for Advanced Solid Tumors at SITC 39th Annual Meeting

  November 7, 2024

   · 

  5 min read
• Press Releases

  Clasp Therapeutics Presents Comprehensive Preclinical Data Validating First-in-Class Precision T Cell Engager Against p53 Mutant Solid Tumors at SITC Annual Meeting

  November 7, 2024

   · 

  2 min read
• Press Releases

  Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Program Targeting the ELANE Pathway at SITC 2024

  November 7, 2024

   · 

  4 min read
• Press Releases

  SOTIO Showcases New Data on SOT201 Immunocytokine, VICTORIA-01 Clinical Study, and BOXR CAR-T Advancements at 2024 SITC Annual Meeting

  November 7, 2024

   · 

  2 min read
• Press Releases

  Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024

  November 7, 2024

   · 

  5 min read
• Press Releases

  Pheast Presents New Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor, at SITC 2024

  November 7, 2024

   · 

  2 min read
• 

  Layoffs

  Viracta Therapeutics Cuts 42% of Staff as Part of Resource Reprioritization

  Following two layoffs in less than three months, Viracta Therapeutics may have around 18 employees left to advance its efforts to bring lead product candidate nana-val to market.

  November 7, 2024

   · 

  2 min read

   · 

  Angela Gabriel
• Press Releases

  Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024

  November 7, 2024

   · 

  1 min read
• Press Releases

  Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting

  November 7, 2024

   · 

  8 min read